Everett Harris & CO Pfizer Inc Transaction History

Everett Harris & CO

  • $7.85 Billion
  • Q4 2024

A detailed history of Everett Harris & CO transactions in Pfizer Inc stock. As of the latest transaction made, Everett Harris & CO holds 224,253 shares of PFE stock, worth $5.73 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
224,253
Previous 218,344 2.71%
Holding current value
$5.73 Million
Previous $6.32 Million 5.84%
% of portfolio
0.08%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025
BUY
$24.8 - $30.19 $146,543 - $178,392
5,909 Added 2.71%
224,253 $5.95 Million
Q3 2024

Oct 18, 2024
BUY
$27.7 - $31.39 $1.08 Million - $1.22 Million
38,870 Added 21.66%
218,344 $6.32 Million
Q2 2024

Aug 01, 2024
BUY
$25.26 - $29.6 $877,835 - $1.03 Million
34,752 Added 24.01%
179,474 $5.02 Million
Q1 2024

Apr 19, 2024
BUY
$25.89 - $29.73 $694,162 - $797,120
26,812 Added 22.74%
144,722 $4.02 Million
Q4 2023

Jan 18, 2024
SELL
$26.13 - $33.94 $6,793 - $8,824
-260 Reduced 0.22%
117,910 $3.39 Million
Q3 2023

Oct 23, 2023
BUY
$32.09 - $37.51 $2,984 - $3,488
93 Added 0.08%
118,170 $3.92 Million
Q2 2023

Jul 26, 2023
BUY
$36.12 - $41.79 $154,376 - $178,610
4,274 Added 3.76%
118,077 $4.33 Million
Q1 2023

Apr 24, 2023
BUY
$39.39 - $51.28 $12,998 - $16,922
330 Added 0.29%
113,803 $4.64 Million
Q4 2022

Jan 20, 2023
SELL
$41.75 - $54.5 $1.35 Million - $1.76 Million
-32,226 Reduced 22.12%
113,473 $0
Q3 2022

Oct 21, 2022
BUY
$43.76 - $53.42 $80,737 - $98,559
1,845 Added 1.28%
145,699 $6.38 Million
Q2 2022

Jul 22, 2022
BUY
$46.53 - $55.17 $356,745 - $422,988
7,667 Added 5.63%
143,854 $7.54 Million
Q1 2022

Apr 22, 2022
BUY
$45.75 - $56.69 $4,346 - $5,385
95 Added 0.07%
136,187 $7.05 Million
Q4 2021

Feb 02, 2022
BUY
$41.32 - $61.25 $50,410 - $74,725
1,220 Added 0.9%
136,092 $8.04 Million
Q3 2021

Nov 03, 2021
BUY
$39.25 - $50.42 $325,971 - $418,738
8,305 Added 6.56%
134,872 $5.8 Million
Q2 2021

Jul 29, 2021
BUY
$35.91 - $40.68 $291,625 - $330,362
8,121 Added 6.86%
126,567 $4.96 Million
Q1 2021

May 13, 2021
BUY
$33.49 - $37.77 $230,913 - $260,424
6,895 Added 6.18%
118,446 $4.29 Million
Q4 2020

Feb 04, 2021
BUY
$33.47 - $42.56 $131,035 - $166,622
3,915 Added 3.64%
111,551 $4.11 Million
Q3 2020

Nov 03, 2020
BUY
$31.75 - $37.25 $107,664 - $126,314
3,391 Added 3.25%
107,636 $3.95 Million
Q2 2020

Jul 29, 2020
BUY
$30.12 - $36.54 $82,619 - $100,229
2,743 Added 2.7%
104,245 $3.41 Million
Q1 2020

Apr 29, 2020
BUY
$27.03 - $38.62 $1.21 Million - $1.73 Million
44,889 Added 79.29%
101,502 $3.31 Million
Q4 2019

Jan 27, 2020
BUY
$32.92 - $37.36 $18,830 - $21,369
572 Added 1.02%
56,613 $2.22 Million
Q3 2019

Nov 06, 2019
SELL
$32.49 - $42.13 $497,519 - $645,136
-15,313 Reduced 21.46%
56,041 $2.01 Million
Q2 2019

Aug 13, 2019
SELL
$36.98 - $41.52 $113,158 - $127,051
-3,060 Reduced 4.11%
71,354 $3.09 Million
Q1 2019

May 13, 2019
BUY
$37.5 - $41.2 $33,112 - $36,379
883 Added 1.2%
74,414 $3.16 Million
Q3 2018

Nov 14, 2018
SELL
$34.47 - $41.81 $15,270 - $18,521
-443 Reduced 0.6%
73,531 $3.24 Million
Q2 2018

Jul 27, 2018
BUY
$32.98 - $35.16 $6,530 - $6,961
198 Added 0.27%
73,974 $2.68 Million
Q1 2018

Apr 20, 2018
BUY
$31.91 - $37.02 $216,541 - $251,217
6,786 Added 10.13%
73,776 $2.62 Million
Q4 2017

Feb 01, 2018
SELL
$33.26 - $35.29 $22,450 - $23,820
-675 Reduced 1.0%
66,990 $2.43 Million
Q3 2017

Oct 11, 2017
BUY
$31.0 - $34.15 $2.1 Million - $2.31 Million
67,665
67,665 $2.42 Million

Others Institutions Holding PFE

# of Institutions
3,346
Shares Held
3.69B
Call Options Held
106M
Put Options Held
123M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $143B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email